Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Gradual vs Abrupt Cessation in COPD
NCT02894957Phase 4Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Continuous Abstinence Rate from week 10 to week 30. Status: unknown.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02894957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894957.